The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 4-Denmark looking to share its unwanted AstraZeneca vaccines-WHO

Thu, 15th Apr 2021 12:38

(Adds number of vaccines, no comment from ministry)

ZURICH, April 15 (Reuters) - Denmark is examining options
for sharing AstraZeneca's vaccines with poorer nations
after it halted use of the shots over concerns about rare blood
clots, the World Health Organization's Europe head said on
Thursday.

Denmark this week became the first country to stop using
AstraZeneca's COVID-19 vaccine altogether, as European officials
investigate reports of rare blood clots combined with low
platelet counts that have occurred in Europe and Britain.

The decision has sparked some debate in Denmark about what
to do with the leftover vaccines. Opposition parties argue the
authorities should make the shots available to Danes willing to
take it.

Denmark currently has just over 200,000 vaccines, but is set
to receive another 3.5 million from previous agreements, the
State Serum Institute told Reuters.

The Danish Health Ministry was not immediately available for
comment.

The WHO, which along with Britain and the European Medicines
Agency (EMA) continue to recommend AstraZeneca's shot on the
grounds that the benefits outweigh the risks, has been pushing
countries not to hoard vaccines that they are not using.

World Bank President David Malpass also called on countries
on Thursday to contribute their "excess" doses of COVID-19
vaccines to low-income countries.

The lion's share of vaccines distributed globally, so far,
have gone to wealthier nations.

"I understand that the ministry of foreign affairs of
Denmark is ready to, or looking already into options, for
sharing AstraZeneca vaccines with poorer countries," WHO Europe
Director Hans Kluge told reporters.

Lithuanian Prime Minister Ingrida Simonyte said her country
would gladly take the shots: "We still have less vaccines then
people willing to be vaccinated. Therefore, Lithuania has
expressed readiness to take as many doses of Astra Zeneca, as
Denmark is ready to share."

WHO and EMA have said every nation should make decisions
about their vaccination programs based on their rates of
vaccination, infection and hospitalisation.

Danish Health Authority director Soren Brostrom said on
Wednesday his country had come far in inoculating the elderly
population most at risk of contracting a serious form of
COVID-19, and that younger groups were at lower risk of
complications from the disease. That had to be weighed against
the possible vaccine side effects, he said.

(Reporting by John Miller in Zurich and Gabriela Baczynska in
Brussels; Editing by Alison Williams and Keith Weir)

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.